| Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells TC Yuan, S Veeramani, MF Lin Endocrine-related cancer 14 (3), 531-547, 2007 | 320 | 2007 |
| Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells TC Yuan, S Veeramani, FF Lin, D Kondrikou, S Zelivianski, T Igawa, ... Endocrine-related cancer 13 (1), 151-167, 2006 | 205 | 2006 |
| Depletion of the C3 component of complement enhances the ability of rituximab-coated target cells to activate human NK cells and improves the efficacy of monoclonal antibody … SY Wang, S Veeramani, E Racila, J Cagley, DC Fritzinger, CW Vogel, ... Blood, The Journal of the American Society of Hematology 114 (26), 5322-5330, 2009 | 163 | 2009 |
| Complement in monoclonal antibody therapy of cancer LM Rogers, S Veeramani, GJ Weiner Immunologic research 59, 203-210, 2014 | 137 | 2014 |
| Rituximab infusion induces NK activation in lymphoma patients with the high-affinity CD16 polymorphism S Veeramani, SY Wang, C Dahle, S Blackwell, L Jacobus, T Knutson, ... Blood, The Journal of the American Society of Hematology 118 (12), 3347-3349, 2011 | 131 | 2011 |
| Cellular prostatic acid phosphatase: a protein tyrosine phosphatase involved in androgen-independent proliferation of prostate cancer S Veeramani, TC Yuan, SJ Chen, FF Lin, JE Petersen, S Shaheduzzaman, ... Endocrine-Related Cancer 12 (4), 805-822, 2005 | 128 | 2005 |
| Mitochondrial redox signaling by p66Shc is involved in regulating androgenic growth stimulation of human prostate cancer cells S Veeramani, TC Yuan, FF Lin, MF Lin Oncogene 27 (37), 5057-5068, 2008 | 93 | 2008 |
| Expression of p66Shc protein correlates with proliferation of human prostate cancer cells S Veeramani, T Igawa, TC Yuan, FF Lin, MS Lee, JS Lin, SL Johansson, ... Oncogene 24 (48), 7203-7212, 2005 | 80 | 2005 |
| p66Shc—A longevity redox protein in human prostate cancer progression and metastasis: p66Shc in cancer progression and metastasis M Rajendran, P Thomes, L Zhang, S Veeramani, MF Lin Cancer and metastasis reviews 29, 207-222, 2010 | 79 | 2010 |
| A novel role of Shc adaptor proteins in steroid hormone-regulated cancers SM Alam, M Rajendran, S Ouyang, S Veeramani, L Zhang, MF Lin Endocrine-related cancer 16 (1), 1-16, 2009 | 65 | 2009 |
| Human prostatic acid phosphatase, an authentic tyrosine phosphatase, dephosphorylates ErbB-2 and regulates prostate cancer cell growth TD Chuang, SJ Chen, FF Lin, S Veeramani, S Kumar, SK Batra, Y Tu, ... Journal of biological chemistry 285 (31), 23598-23606, 2010 | 61 | 2010 |
| Chemoimmunotherapy for relapsed/refractory and progressive 17p13‐deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low‐dose rituximab is … CS Zent, RP Taylor, MA Lindorfer, PV Beum, B LaPlant, W Wu, TG Call, ... American journal of hematology 89 (7), 757-765, 2014 | 41 | 2014 |
| Reactive oxygen species induced by p66Shc longevity protein mediate nongenomic androgen action via tyrosine phosphorylation signaling to enhance tumorigenicity of prostate … S Veeramani, YW Chou, FC Lin, S Muniyan, FF Lin, S Kumar, Y Xie, ... Free Radical Biology and Medicine 53 (1), 95-108, 2012 | 36 | 2012 |
| ErbB-2 via PYK2 upregulates the adhesive ability of androgen receptor-positive human prostate cancer cells TC Yuan, FF Lin, S Veeramani, SJ Chen, HS Earp, MF Lin Oncogene 26 (54), 7552-7559, 2007 | 36 | 2007 |
| Revisiting histidine-dependent acid phosphatases: a distinct group of tyrosine phosphatases S Veeramani, MS Lee, MF Lin Trends in biochemical sciences 34 (6), 273-278, 2009 | 23 | 2009 |
| p66Shc longevity protein regulates the proliferation of human ovarian cancer cells S Muniyan, YW Chou, TJ Tsai, P Thomes, S Veeramani, BB Benigno, ... Molecular carcinogenesis 54 (8), 618-631, 2015 | 18 | 2015 |
| Optimization of RNA aptamer SELEX methods: improved aptamer transcript 3′-end homogeneity, PAGE purification yield, and target-bound aptamer RNA recovery C Narayan, S Veeramani, WH Thiel nucleic acid therapeutics 32 (1), 74-80, 2022 | 5 | 2022 |
| An RNA Aptamer–Based Biomarker Platform Demonstrates High Soluble CD25 Occupancy by IL2 in the Serum of Follicular Lymphoma Patients S Veeramani, SE Blackwell, WH Thiel, ZZ Yang, SM Ansell, ... Cancer immunology research 7 (9), 1511-1522, 2019 | 5 | 2019 |
| 5.4 ROLE OF REACTIVE OXYGEN SPECIES IN CARCINOGENESIS S VEERAMANI, MF LIN Redox biochemistry, 212, 2007 | 5 | 2007 |
| Selection of a novel cell-internalizing RNA aptamer specific for CD22 antigen in B cell acute lymphoblastic leukemia D Ruiz-Ciancio, LH Lin, S Veeramani, MN Barros, D Sanchez, ... Molecular Therapy-Nucleic Acids 33, 698-712, 2023 | 2 | 2023 |
